Revolutionary CRISPR gene editing technology designed for one-time treatment, targeting the genetic foundations of disease rather than managing symptoms
Advanced CRISPR editing technology with proprietary delivery systems, designed for safety and lasting efficacy
Next-generation gene editing tools engineered for precision targeting of disease-causing genetic variants with enhanced safety profiles.
Proprietary delivery mechanisms specifically designed for gastrointestinal targeting, ensuring therapeutic molecules reach the right cells.
Rigorous safety protocols and efficacy validation, following international gene therapy guidelines with comprehensive risk assessment.
Our approach addresses key genetic factors in disease pathogenesis, targeting root causes rather than downstream effects.
Unlike current therapies that require lifelong management, our approach is designed to provide lasting therapeutic benefit through a single treatment course.
By addressing the genetic foundations of Crohn's disease, we aim to restore normal cellular function and provide patients with a functional cure, not just symptom relief.
Strategic roadmap from pre-clinical research to clinical application
Foundational stage focusing on initial research and concept development. Establishing scientific framework and seeking pre-seed funding to advance toward pre-clinical development phase.
Begin active development and validation of our proprietary gene editing approach. Optimizing delivery systems and conducting comprehensive safety assessments in laboratory models.
Engaging with MHRA and FDA to establish clear regulatory pathways. Establishing strategic partnerships with leading GMP manufacturing facilities and preparing comprehensive documentation following gene therapy guidelines.
Planned progression to Phase I clinical trials to evaluate safety and preliminary efficacy. Careful patient selection and comprehensive monitoring protocols following established clinical trial frameworks.
The transformative impact of a functional cure for Crohn's disease
Patients currently face lifelong medication regimens with significant side effects. A functional cure would restore normal life quality and eliminate the burden of chronic disease management.
Freedom from daily medications, reduced hospitalizations, and return to normal activities. Patients could focus on living their lives rather than managing their disease.
Significant reduction in long-term healthcare costs, decreased hospital admissions, and reduced burden on healthcare resources through prevention of disease progression.
A functional cure represents massive economic value through reduced lifetime treatment costs, increased productivity, and elimination of chronic care requirements.
Rigorous development following international standards
We welcome collaborations with leading research institutions, clinical partners, and investors who share our vision of developing breakthrough therapies for Crohn's disease.